Paget-Schroetter disease secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paget-Schroetter disease}} | {{Paget-Schroetter disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Anahita}} | ||
==Overview== | ==Overview== |
Latest revision as of 20:23, 23 June 2020
Paget-Schroetter disease Microchapters |
Differentiating Paget-Schroetter disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget-Schroetter disease secondary prevention On the Web |
American Roentgen Ray Society Images of Paget-Schroetter disease secondary prevention |
Risk calculators and risk factors for Paget-Schroetter disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
There are no established measures for the secondary prevention of Paget-Schroetter disease.
Secondary Prevention
- There are no established measures for the secondary prevention of Paget-Schroetter disease.